France is the next front in the coronavirus battle France is the next front in the coronavirus battle France is the next front in the coronavirus battle

France is the next front in the coronavirus battle

Christopher Dembik

Head of Macroeconomic Research

Summary:  To contain the spread of the COVID-19, France might announce a strict quarantine in the next two days and the postponement of the second round of the local election initially scheduled for next Sunday.

France is one of the main European hotspots for the coronavirus pandemic, with 5,423 confirmed cases and 127 deaths. Over the past few days, France has implemented lockdown measures, such as the closure of schools, universities and nearly all shops (at least until April 15) and favoring remote work for all employees This morning, the government confirmed that “the number of affected people double every three days and the situation is deteriorating very quickly”. As part of the population, especially in main cities such as Paris, is not respecting the “social distancing” advice, France might be compelled to implement a strict quarantine for some cities in the next two days. According to most health experts, it would be the only solution to contain the virus and reduce the impact on hospitals and the wider healthcare system. It would mean that the second round of the local election, initially scheduled for next Sunday, would be postponed until further notice. France has probably two to three though weeks ahead.

President Macron had his “Draghi moment”. In his latest speech to the Nation, he confirmed that the government will do “whatever it costs” (mentioned three times) to deal with the crisis. After the contraction in GDP in Q4 2019, France might already be in recession with output falling more than in 2008/09. The following measures has already been taken:

  • Public credit guarantee scheme for SMEs, for about €3 billion.
  • Partial unemployment scheme, for about €15 to 20 billion if the crisis lasts longer than one month.
  • Tax and social contribution deferral, that would represents around €15 to 20 billion.

Under pressure from the government, banks also announced a six-month moratorium on loan repayments for businesses.

The total size of the package is estimated to be between €30 to 40 billion by the French government, which is about 1% of annual GDP. However, it is likely insufficient to tackle the economic crisis.

Most businesses are not ready to face the current situation. For those with a contingency plan, the most extreme scenario is usually a 10-20% hit to revenue. Given the sudden economic stop, it may reach 75% to 90%. A major difference with other crisis is that it is broad-based. Not a single economic sector is spared by the COVID-19 and its consequences. In times of recession, it is estimated that around 60% to 70% of businesses are affected. The current crisis affects almost 100% of companies, particularly in countries where containment measures have been put in place, such as France.

Most observers estimate that financial difficulties for small businesses could rise two to three months after the COVID-19 outbreak if conditions fail to normalize. We are already one month into the crisis and, given the recent lockdown measures, it may last at least until mid- or end of April. It means that many small businesses may face cash flow problems and risk of bankruptcies in April/May if the government does not bailout SMEs.

At this stage, a bigger package that could push the total stimulus above €100 billion is almost unavoidable. It could include business tax cuts with immediate effect on activity, a small businesses’ solidarity fund of tens of billions of euros and demand-oriented measures. In a second step, fiscal stimulus could consist in higher public investment. It usually has the longest lag between the implementation and the impact on business activity, but it can provide more visibility to companies regarding their order books for the forthcoming quarters.


Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (
- Analysis Disclaimer (
- Notification on Non-Independent Investment Research (

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.